tiprankstipranks
Trending News
More News >
Arrowhead Pharmaceuticals (ARWR)
NASDAQ:ARWR
US Market
Advertisement

Arrowhead Pharmaceuticals (ARWR) Ownership - Who Owns Arrowhead Pharmaceuticals?

Compare
1,641 Followers

Arrowhead Pharmaceuticals (ARWR) Ownership Overview

4.10%17.70%6.01%26.59%45.61%
6.01% Other Institutional Investors
26.59% ETFs
45.61% Public Companies and
Individual Investors
The ownership structure of Arrowhead Pharmaceuticals (ARWR) stock is a mix of institutional, retail, and individual investors. Approximately 50.30% of the company’s stock is owned by Institutional Investors, 4.10% is owned by Insiders, and 45.61% is owned by Public Companies and Individual Investors.
The ownership structure of Arrowhead Pharmaceuticals (ARWR) stock is a mix of institutional, retail, and individual investors. Approximately 23.71% of the company’s stock is owned by Institutional Investors, 4.10% is owned by Insiders, and 26.59% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Dec 01, 2025
xxxxxxxxxxxxx
$493413
Apr 11, 2025
xxxxxxxxxxxxx
$1533337
Mar 17, 2025
xxxxxxxxxxxxx
$774975
Jan 07, 2025
xxxxxxxxxxxxx
$196900

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Sep 30, 2025
xxxxxxxxxxxxx
$34248570
Sep 30, 2025
xxxxxxxxxxxxx
$34495449
Sep 30, 2025
xxxxxxxxxxxxx
$36345355
Sep 30, 2025
xxxxxxxxxxxxx
$57624581

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
18,244,409Institution13.20%750,574,986
12,340,795Institution8.93%507,700,306
10,281,846Institution7.44%422,995,144
5,232,000Institution3.78%215,244,480
3,921,255Insider2.84%161,320,431
3,697,084Institution2.67%152,098,036
2,796,336Institution2.02%115,041,263
1,302,852Institution0.94%53,599,331
1,265,123Institution0.92%52,047,160
1,053,794Institution0.76%43,353,085

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
10,281,846Institution7.44%422,995,144
2,796,336Institution2.02%115,041,263
1,302,852Institution0.94%53,599,331
1,265,123Institution0.92%52,047,160
1,040,054Institution0.75%42,787,822
912,509Institution0.66%37,540,620
823,524Institution0.60%33,879,777
681,095Institution0.49%28,020,248
566,441Institution0.41%23,303,383
534,313Institution0.39%21,981,637

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
8,098,803Institution5.86%333,184,755
4,175,072Institution3.02%143,998,233
3,364,205Institution2.43%79,798,943
3,113,166Institution2.25%107,373,095
2,945,741Institution2.13%121,187,785
1,742,001Institution1.26%60,081,614
1,510,090Institution1.09%62,547,928
1,480,437Institution1.07%51,060,272
1,186,855Institution0.86%49,159,534
1,055,632Institution0.76%43,428,700

FAQ

Who Owns Arrowhead Pharmaceuticals (ARWR)?
According to the latest TipRanks data, approximately 6.01% of the company's stock is held by institutional investors, 4.10% is held by insiders, and 45.61% is held by retail investors.
    What percentage of Arrowhead Pharmaceuticals (ARWR) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 6.01% of Arrowhead Pharmaceuticals (ARWR) stock is held by institutional investors.
      What percentage of Arrowhead Pharmaceuticals (ARWR) stock is held by retail investors?
      According to the latest TipRanks data, approximately 45.61% of Arrowhead Pharmaceuticals (ARWR) stock is held by retail investors.
        Who owns the most shares of Arrowhead Pharmaceuticals (ARWR)?
        iShares owns the most shares of Arrowhead Pharmaceuticals (ARWR).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis